Today in News History
On July 12, several notable moments in the history of News stand out. In 1863, Albert Calmette, French physician, bacteriologist, and immunologist (died 1933) was born. In 1895, Buckminster Fuller, American architect and engineer, designed the Montreal Biosphère (died 1983) was born. In 1910, Charles Rolls, English engineer and businessman, co-founded Rolls-Royce Limited (born 1877) passed away. In 1928, Elias James Corey, American chemist and academic, Nobel Prize laureate was born. In 1935, Satoshi Ōmura, Japanese biochemist and academic, Nobel Prize laureate was born. In 1954, Wolfgang Dremmler, German footballer and coach was born. In 1969, Anne-Sophie Pic, French chef was born. In 1997, François Furet, French historian and author (born 1927) passed away. In 2005, John King, Baron King of Wartnaby, English businessman (born 1917) passed away. In 2024, Ruth Westheimer, German-American sex therapist (born 1928) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.
Germany’s Merck to Buy Bio-Techne for $11 Billion
Merck KGaA offered 73 a share in cash for Bio-Techne, representing a 24 premium to the U.S. lab-tools supplier’s closing price Wednesday.
Narrative Intelligence Brief
This article was published by The Wall Street Journal - Business, a source frequently categorized with a lean right bias based in United States of America. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of The Wall Street Journal - Business, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.
More from The Wall Street Journal - Business
July 11, 2026
A New Foe Has Emerged for Data Centers: Farmers
July 11, 2026
Washington’s Bet on Intel Is Starting to Pay Off
July 11, 2026
News Quiz for July 11, 2026
July 11, 2026
The Mind-Bending Company That Gets a Million Job Applications—and Rejects 99.9%
July 11, 2026
The Company That Owns AOL Gets a Million Job Applications—and Rejects 99.9%
Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.More Coverage
Discussion
"cup semifinals"
Jude Bellingham's star shines as risk-averse England advance to World Cup semifinals over tepid Norway
Bellingham carries England past Norway and into World Cup semifinals
England defeat Norway 2-1 as Jude Bellingham shines in World Cup quarterfinal
How other outlets are covering this story
Compare narratives across 4 related reports from 4 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.
Coverage bias distribution
4 sources
Left 25%
Center 25%
Right 50%
ArcaMax
· Jun 26, 2026
Bio-Techne will be sold for $11.3B, one of largest deals in Minnesota history
Germany’s Merck KGaA will buy Bio-Techne Corp. in a deal worth 11.3 billion, one of the largest acquisitions in Minnesota history. The sale follows investor pressure on Minneapolis-based Bio-Techne, which makes lab materials and equipment used...
The Eastern Herald
· Jun 26, 2026
Merck KGaA to Pay $11.3 Billion for Bio-Techne in Life Sciences Tools Bet
Germany's Merck KGaA agreed to pay 73 a share in cash for Bio-Techne Corp. TECH, a 36 premium valuing the Minneapolis life sciences tools group at 11.3 billion. The acquisition, the company's biggest since Sigma-Aldrich, gives Merck KGaA a catalog of 425,000 antibodies and emerging spatial biology platforms at the center of drug discovery.
The Motley Fool
· Jun 30, 2026
This Pharmaceutical Giant Just Poured $11 Billion on an Acquisition. Time to Buy?
AbbVie knows how to plan ahead.
Seeking Alpha
· Jun 29, 2026
Biotech Is The Rate Cut Trade In Disguise
Biotech Is The Rate Cut Trade In Disguise
Topics:
Related coverage for "Germany’s Merck to Buy Bio-Techne for $11 Billion": ArcaMax — Bio-Techne will be sold for $11.3B, one of largest deals in Minnesota history. The Eastern Herald — Merck KGaA to Pay $11.3 Billion for Bio-Techne in Life Sciences Tools Bet. The Motley Fool — This Pharmaceutical Giant Just Poured $11 Billion on an Acquisition. Time to Buy?. Seeking Alpha — Biotech Is The Rate Cut Trade In Disguise